1. Home
  2. HURC vs AGEN Comparison

HURC vs AGEN Comparison

Compare HURC & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HURC

Hurco Companies Inc.

HOLD

Current Price

$17.43

Market Cap

107.3M

Sector

Industrials

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$2.94

Market Cap

126.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURC
AGEN
Founded
1968
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.3M
126.2M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
HURC
AGEN
Price
$17.43
$2.94
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
30.7K
883.1K
Earning Date
03-06-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$178,554,000.00
$106,829,000.00
Revenue This Year
N/A
$5.19
Revenue Next Year
N/A
$68.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.19
$1.38
52 Week High
$23.45
$7.34

Technical Indicators

Market Signals
Indicator
HURC
AGEN
Relative Strength Index (RSI) N/A 35.33
Support Level N/A $2.71
Resistance Level N/A $2.96
Average True Range (ATR) 0.00 0.18
MACD 0.00 -0.05
Stochastic Oscillator 0.00 8.33

Price Performance

Historical Comparison
HURC
AGEN

About HURC Hurco Companies Inc.

Hurco Companies Inc is an international industrial technology company that designs, manufactures, and sells computerized (CNC) machine tools for the metal cutting industry through a international sales and distribution network. Its proprietary control systems and software are sold as integral components of its machine tools. The Company also provides machine tool components, automation solutions, software options, upgrades, accessories, replacement parts, and related support services. It operates in the Americas, Europe, and Asia Pacific, with the Americas contributing the majority of revenue. Its core products include vertical and horizontal machining centers (mills), turning centers (lathes), and toolroom machines.

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

Share on Social Networks: